glp-1 sequence (9-36), Glucagon-like Peptide 1 Structure and function studies of

It is known that the CV protection effect of GLP-1RAs have been proven through eight large-scale clinical studies, including Evaluation of LIXisenatide in Acute coronary syndrome (ELIXA) [66], LEADER [44], Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes (SUSTAIN)-6 [67], Exenatide Study of Cardiovascular Event Lowering (EXSCEL) [68], Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes) [69], Researching Cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) [70], Peptide Innovation for Early Diabetes Treatment (PIONEER) 6 [67,71], and AMPLITUDE-O [51]

Some clinical studies have also observed reductions in markers associated with leaky gut after taking prebiotic supplements

Cost analysis: is the 60 mg vial worth it

NPJ Biofilms Microbiomes 11:27

Enabling these alerts can take the guesswork out of your refill schedule